Current Neuropharmacology

Editor-in-Chief

Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 13 Issue: 5, September 2015



Meet Our Editorial Board Member: free to download

Volume:13   Issue: 5
Pp: 555-555
Michel Baudry
DOI: 10.2174/1570159X1305151013194644
Published on: 13 October, 2015



Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders) free to download

Volume:13   Issue: 5
Pp: 556-557
Andre F. Carvalho and Roger S. McIntyre
DOI: 10.2174/1570159X1305151013195022
Published on: 13 October, 2015

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments

Volume:13   Issue: 5
Pp: 558-576
Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre
DOI: 10.2174/1570159X13666150630171433
Published on: 30 June, 2015


Treatment-resistant Late-life Depression: Challenges and Perspectives

Volume:13   Issue: 5
Pp: 577-591
Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel
DOI: 10.2174/1570159X1305151013200032
Published on: 13 October, 2015


Pharmacological Approaches for Treatment-resistant Bipolar Disorder

Volume:13   Issue: 5
Pp: 592-604
Shi Hui Poon, Kang Sim and Ross J. Baldessarini
DOI: 10.2174/1570159X13666150630171954
Published on: 30 June, 2015


From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings

Volume:13   Issue: 5
Pp: 605-615
Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho
DOI: 10.2174/1570159X13666150630174343
Published on: 30 June, 2015


Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics

Volume:13   Issue: 5
Pp: 616-635
Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira
DOI: 10.2174/1570159X13666150630173522
Published on: 30 June, 2015


Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review

Volume:13   Issue: 5
Pp: 636-655
Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho
DOI: 10.2174/1570159X13666150630175044
Published on: 30 June, 2015


Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

Volume:13   Issue: 5
Pp: 656-662
Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean
DOI: 10.2174/1570159X13666150630175841
Published on: 30 June, 2015


Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Volume:13   Issue: 5
Pp: 663-680
Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel
DOI: 10.2174/1570159X13666150630173047
Published on: 30 June, 2015


The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

Volume:13   Issue: 5
Pp: 681-691
Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington
DOI: 10.2174/1570159X13666150115220221
Published on: 15 January, 2015


The Management and Outcomes of Pharmacological Treatments for Tinnitus

Volume:13   Issue: 5
Pp: 692-700
Devon Beebe Palumbo, Kathleen Joos, Dirk De Ridder and Sven Vanneste
DOI: 10.2174/1570159X13666150415002743
Published on: 14 April, 2015

Myalgic Encephalomyelitis: Symptoms and Biomarkers

Volume:13   Issue: 5
Pp: 701-734
Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn
DOI: 10.2174/1570159X13666150928105725
Published on: 27 September, 2015